LYG-202, a new flavonoid with a piperazine substitution, shows antitumor effects in vivo and in vitro.
|
| Abstract |
LYG-202 is a newly synthesized flavonoid with a piperazine substitution. We investigated the antitumor effect of LYG-202 in vivo and in vitro. We show that, LYG-202 significantly decreases tumor growth in mice inoculated with S180 sarcoma cells, compared with the control group. Meanwhile, the viabilities of various kinds of tumor cells were inhibited by LYG-202 with IC(50) values in the range of 4.80 to 27.70 microM. Then apoptosis induced by LYG-202 in HepG2 cells was characterized by DAPI staining and Annexin V/PI double staining and degradation of PARP was observed. Activation of the caspase cascade for both the extrinsic and intrinsic pathways was demonstrated, including caspase-8, -9, and -3. The results also showed that the expression of Bcl-2 protein decreased whereas that of Bax protein increased, leading to an increase of the Bax/Bcl-2 ratio. Our results demonstrated that LYG-202 exhibited strong antitumor effect in vivo and in vitro, involving with apoptosis induction.
|
|---|---|
| Authors | Shi Zeng, Wei Liu, Fei-Fei Nie, Qing Zhao, Jing-Jing Rong, Jia Wang, Lei Tao, Qi Qi, Na Lu, Zhi-Yu Li, Qing-Long Guo |
| Journal | Biochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 385 Issue 4 Pg. 551-6 (Aug 07 2009) ISSN: 1090-2104 [Electronic] United States |
| PMID | 19481059 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't) |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!